Table 6.
not necessarily in order of commencement or completion
“DRAFT” below refers to versions of the CPG development activities no shading, DIER activities shaded |
development | dissemination | implementation | evaluation | revision | |
---|---|---|---|---|---|---|
1 | appoint editorial advisors (editor-in-chief, senior editorial consultant) | yes | yes | yes | yes | yes |
2 | create CPG template (tightly linked to AGREE instrument) that guides content development | yes | yes | |||
3 | create terms of reference & appoint independent review panels | yes | yes | |||
4 | create dissemination, implementation, evaluation, revision (DIER) plan | yes | yes | yes | yes | yes |
5 | release evidence-assessor request for proposal with template & levels of evidence rating table
– evaluate proposals using a standardized scoring grid |
yes | ||||
6 | DRAFT-A to -B – evidence-assessor finalizes first draft of CPG | yes | ||||
7 | DRAFT-B to -C – GDC (formal authors) reviews DRAFT-B | yes | ||||
8 | DIER approved & create and publish DevDIER (this report) | yes | yes | |||
9 | DRAFT-C to -D – review panel reviews DRAFT-C
– validate clinical accuracy and advise GDC about Grade-D recommendations – validate clinical applicability of all recommendations |
yes | yes | |||
10 | practitioners and interested parties anonymously critique DRAFT-D about its clinical utility
– using a structured Internet-based consultation based on the AGREE; i.e., an eQuestionnaire and a structured text feedback mechanism |
yes | yes | yes | ||
11 | DRAFT-D to -E – incorporate feedback from practitioners and interested parties | yes | ||||
12 | inform stakeholder organizations about the impact of feedback from #10 on CPG | yes | ||||
13 | initiate AGREE collaboration – to evaluate final CPG (DRAFT-G) using the AGREE instrument, with a view to publishing results | yes | yes | yes | yes | |
14 | DRAFT-E to -F – GDC (formal authors) reviews DRAFT-E | yes | ||||
15 | DRAFT-F to -G – JTF and The CCA & CFCRB Boards formally accept DRAFT-F | yes | ||||
16 | submit final CPG (DRAFT-G) to the JCCA for peer revue and acceptance | yes | ||||
17 | undertake self-report CPG tri-evaluation – front-line evaluation of document caliber, self-reported use rates, self-reported clinical outcomes | yes | yes | yes | ||
18 | facilitate a formal outcomes research evaluation study | yes | yes | yes | ||
19 | create publications for the lay-public & patients using the CPG | yes | yes | |||
20 | facilitate the incorporation of the CPG into education, continuing education, licencing | yes | yes | |||
21 | create CPG-specific newsletter articles – best-of implementor bios, best-of implementation write-ups, case-studies for problem-solving, feedback channel for practitioners, patient feedback, updates on CPG process/progress | yes | yes | yes | ||
22 | create and disseminate case-study template to drive newsletter article submissions | yes | yes | yes | ||
23 | create and disseminate briefing notes about the impact of each CPG on various policy issues | yes | yes | |||
24 | manage the update or revision of the publicized CPG – evaluate need for update/revision every 6 months, formal revision every 18 months expected | yes | yes |